Form 8.3 - Horizon Therapeutics plc

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Horizon Therapeutics plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BQPVQZ61

Date of dealing

2nd May 2023

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,722,150

(2.064%)

101

(0.000%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

287,600

(0.126%)

1,302,800

(0.569%)

Total

5,009,750

(2.190%)

1,302,901

(0.570%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

1. DEALINGS (Note 4)

a. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD) (Note 5)

Purchase

1,067

111.92

Purchase

137

111.91

Purchase

200

111.95

Purchase

2,106

111.94

Sale

114

111.76

Sale

41

111.79

Purchase

114

112.00

Purchase

1,490

111.93

Purchase

204

111.91

Purchase

92

111.95

Purchase

366

111.94

Purchase

1,363

111.76

Sale

995

111.76

Purchase

1

111.79

Purchase

1,252

111.89

Purchase

656

111.78

Purchase

96

111.86

Purchase

604

111.98

Purchase

351

111.97

Purchase

43

111.71

Purchase

997

111.82

Purchase

592

111.93

Purchase

239

111.81

Purchase

1,416

111.73

Purchase

581

111.77

Purchase

223

111.67

Purchase

405

111.69

Purchase

104

111.84

Purchase

6

111.88

Purchase

834

111.74

Purchase

127

111.72

Purchase

1,485

111.85

Purchase

4

111.83

Purchase

211

111.80

Purchase

6

111.66

Purchase

112

111.70

Purchase

192

111.64

Sale

66

111.76

Sale

35

111.77

Sale

100

111.92

Purchase

12

111.91

Sale

1,939

111.91

Purchase

119

111.95

Sale

200

111.95

Purchase

640

111.94

Sale

100

111.94

Purchase

1,462

111.76

Sale

691

111.76

Purchase

263

111.79

Sale

1,637

111.79

Sale

3,836

111.89

Purchase

69

111.78

Sale

3,656

111.78

Purchase

693

111.86

Sale

370

111.86

Purchase

100

111.98

Purchase

8,018

112.00

Sale

437

111.71

Purchase

541

111.82

Sale

548

111.82

Purchase

352

111.93

Sale

1,207

111.93

Purchase

5,202

111.81

Sale

3,309

111.81

Purchase

3,972

111.73

Sale

3,859

111.73

Purchase

200

111.68

Sale

98

111.68

Purchase

1,075

111.77

Sale

1,607

111.77

Sale

125

111.67

Purchase

600

111.69

Sale

3,260

111.69

Sale

4,767

111.90

Purchase

219

111.87

Sale

6,082

111.87

Purchase

664

111.84

Sale

5,576

111.84

Purchase

60

111.88

Sale

3

111.88

Purchase

467

111.74

Sale

3,848

111.74

Purchase

164

111.72

Sale

3,050

111.72

Purchase

152

111.85

Sale

5,496

111.83

Purchase

100

111.96

Purchase

104

111.80

Sale

500

111.80

Sale

6,555

111.75

Purchase

103

111.66

Sale

100

111.66

Purchase

393

111.70

Sale

645

111.70

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

(Note 5)

 

 

 

 

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

Call Option

Writing

400

100.00

American

5/12/2023

 

Call Option

Writing

400

101.00

American

5/12/2023

 

Call Option

Writing

400

102.00

American

5/12/2023

 

Call Option

Writing

400

103.00

American

5/12/2023

 

Call Option

Writing

400

104.00

American

5/12/2023

 

Call Option

Writing

400

105.00

American

5/12/2023

 

Call Option

Writing

400

106.00

American

5/12/2023

 

Call Option

Writing

400

107.00

American

5/12/2023

 

Call Option

Writing

400

108.00

American

5/12/2023

 

Call Option

Writing

400

109.00

American

5/12/2023

 

Call Option

Writing

400

110.00

American

5/12/2023

 

Call Option

Writing

400

111.00

American

5/12/2023

 

Put Option

Writing

600

100.00

American

5/12/2023

 

Put Option

Writing

800

101.00

American

5/12/2023

 

Put Option

Writing

700

102.00

American

5/12/2023

 

Put Option

Writing

700

103.00

American

5/12/2023

 

Put Option

Writing

1,000

104.00

American

5/12/2023

 

Put Option

Writing

1,000

105.00

American

5/12/2023

 

Put Option

Writing

1,000

106.00

American

5/12/2023

 

Put Option

Writing

1,000

107.00

American

5/12/2023

 

Put Option

Writing

1,000

108.00

American

5/12/2023

 

Put Option

Writing

1,000

109.00

American

5/12/2023

 

Put Option

Writing

1,000

110.00

American

5/12/2023

 

Put Option

Writing

1,000

111.00

American

5/12/2023

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

d. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

3rd May 2023

Contact name

Sirina Kumar

Telephone number

+44 203 192 8741

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making
disclosure:

Millennium International Management LP

Name of offeror/offeree in relation
to whose relevant securities the
disclosure relates:

Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of
relevant
security

Product
description
e.g. call
option

Written or
purchased

Number of
securities to
which option
or derivative
relates

Exercise
price
per unit

(USD)

Type
e.g.
American,
European
etc.

Expiry
date

IE00BQPVQZ61

Put Option

Purchased

1,100

90.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

11,500

110.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Written

262,400

115.00

American

5/19/2023

IE00BQPVQZ61

Call Option

Purchased

42,500

120.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

55,400

110.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

2,900

80.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

300

80.00

American

1/17/2025

IE00BQPVQZ61

Put Option

Purchased

300

90.00

American

1/19/2024

IE00BQPVQZ61

Call Option

Purchased

1,200

110.00

American

8/18/2023

IE00BQPVQZ61

Call Option

Written

201,200

115.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Written

221,000

80.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

254,200

100.00

American

5/19/2023

IE00BQPVQZ61

Put Option

Purchased

3,600

105.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

10,900

105.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Written

100,000

115.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

46,600

85.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

155,000

100.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

300

110.00

American

6/16/2023

IE00BQPVQZ61

Put Option

Purchased

200,000

100.00

American

8/18/2023

IE00BQPVQZ61

Put Option

Purchased

3,500

95.00

American

6/16/2023

IE00BQPVQZ61

Call Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Put Option

Written

300

110.00

American

7/21/2023

IE00BQPVQZ61

Call Option

Written

400

100.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

101.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

102.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

103.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

104.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

105.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

106.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

107.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

108.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

109.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

110.00

American

5/12/2023

IE00BQPVQZ61

Call Option

Written

400

111.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

600

100.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

800

101.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

700

102.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

700

103.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

104.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

105.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

106.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

107.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

108.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

109.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

110.00

American

5/12/2023

IE00BQPVQZ61

Put Option

Written

1,000

111.00

American

5/12/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET
Sequence Number: 1090306
Time of Receipt (offset from UTC): 20230503T145210+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.